GLP-1 is strictly for laboratory research and is commonly employed in the following investigational areas:

Incretin Pathway & Metabolic Flux

GLP-1 is utilized as a chemical probe to study the biophysics of incretin receptor activation. Researchers employ this peptide to quantify the dose-dependent stimulation of adenylate cyclase and the subsequent enhancement of glucose-dependent insulin secretion pathways in isolated cellular models.

Pancreatic Beta-Cell Survival & Apoptosis

In vitro studies utilizing immortalized pancreatic beta-cell lines and primary islets employ GLP-1 to observe its cytoprotective impact. Investigations focus on how GLP-1 receptor activation significantly reduces biochemical markers of ER stress, attenuates the downregulation of insulin translation, and promotes beta-cell adaptation and survival.

Neurometabolic & Extra-Pancreatic Signaling

Because GLP-1 receptors are expressed in multiple extra-pancreatic tissues, including the central nervous system, GLP-1 is used in neurobiological research to study its role as a neuropeptide. Assays investigate its potential neuroprotective effects, reduction of neuroinflammation, and regulation of metabolic homeostasis via the gut-brain axis.

Pathway / Mechanistic Context

The primary mechanism of action for GLP-1 in research settings involves the targeted activation of the GLP-1 receptor.

• Receptor Activation: Under experimental conditions, GLP-1 binds to GLP-1R, a Gs protein-coupled receptor found predominantly on pancreatic beta cells and specific neural populations.
• Signal Transduction: This binding event directly stimulates adenylate cyclase, leading to a rapid accumulation of intracellular cyclic AMP (cAMP) and the activation of Protein Kinase A (PKA) and Epac2.
• Resulting Flux: Elevated cAMP triggers the closure of ATP-sensitive K+ channels, leading to membrane depolarization and the opening of voltage-dependent Ca2+ channels, which drive the exocytosis of insulin. Simultaneously, PKA-dependent pathways downregulate pro-apoptotic signals (like caspase activity) to preserve cellular mass.

Preclinical Research Summary

Published preclinical literature documents investigations of GLP-1 across multiple experimental models for pathway characterization:

• Beta-Cell Dynamics: Studies in isolated cellular models have observed that GLP-1 receptor activation rapidly reduces ER stress-associated beta-cell death and significantly promotes cell viability.
• Insulinotropic Assays: Research indicates that the administration of GLP-1 in metabolic models alters cellular energy homeostasis, enhancing insulin secretory responses strictly in the presence of elevated glucose levels, confirming its incretin effect.
• Pleiotropic Effects: Broad-spectrum molecular metabolic data suggest that treatment with GLP-1 family peptides can trigger cardio- and neuroprotective pathways, reducing oxidative stress and inflammatory cytokine production.

Form & Analytical Testing

This material is produced via robust chemical synthesis and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm molecular weight and identity.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the ≥99% purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Müller, T. D., Finan, B., Bloom, S. R., D’Alessio, D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular metabolism, 30, 72-130. https://doi.org/10.1016/j.molmet.2019.09.010
• Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiological reviews, 87(4), 1409-1439. https://doi.org/10.1152/physrev.00034.2006
• Yusta, B., Baggio, L. L., Estall, J. L., et al. (2006). GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell metabolism, 4(5), 391-406. https://doi.org/10.1016/j.cmet.2006.10.001
• Li, Y., Hansotia, T., Yusta, B., et al. (2003). Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. Journal of Biological Chemistry, 278(1), 471-478. https://doi.org/10.1074/jbc.M209423200

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.